Mr Fan will report to Jinan Song, the company’s chairman and CEO, and will be responsible for all aspects of China-Biotics’s finance functions, including accounting, financial planning, tax, treasury and audit.
Prior to joining China-Biotics, Mr Fan was vice president and senior equity analyst for Brean Murray, Carret & Co, where he covered the Chinese healthcare industry.
Mr Fan holds a MBA degree in finance from New York University, a master of science degree in medicinal chemistry from the University of Michigan and a bachelor of arts degree with honors in biology and chemistry from Luther College.
Mr Song said: “I want to thank Raymond for his dedicated contributions as our CFO. He steered this company through its first public financing and has been chiefly responsible for our transition last year to the Nasdaq global market. We look forward to his continuing input and experience.
“We are also excited to welcome Lewis as our new CFO. His combined technical knowledge in both finance and science will be an ideal fit as we move into the next phase of our life as a public company.”